|
|
Other links at Articles > Hematology-Oncology |
| 3. |
Exemestane May Improve Survival After Tamoxifen Therapy
|
|
|
In women with early-stage, hormone receptor-positive breast cancer, extended therapy with the steroidal aromatase inhibitor exemestane after 5 years of treatment with tamoxifen significantly improves relapse-free survival, according to an analysis of the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-33 trial. Reuters Health Information
|
|
|